CDISC中国协调委员会

找回密码
立即注册
发新帖

收听

听众

主题
发表于 2015-8-10 10:38:47 | 查看: 7296| 回复: 4
热烈祝贺自即日起C3C官网获得乌普萨拉监测中心(UMC)友情赞助,UMC将赞助2015年C3C官网维护费用,及C3C外地讲者差旅费用。

01a_UMC_logo_horizontal.jpg

关于乌普萨拉监测中心(UMC)
The Uppsala Monitoring Centre (UMC) is an independent foundation and a centre for international service and scientific research.

Our priorities are the safety of patients and the safe and effective use of medicines in every part of the world.

We meet these priorities by innovative research and development, and by providing data, reference, consultative and training resources to medicines regulatory agencies, health professionals, researchers and the pharmaceutical industry all over the world.

Our Vision is a world where all patients and health professionals make wise therapeutic decisions in their use of medicines.

For more information, please visit: http://www.who-umc.org/



发表于 2015-8-11 10:48:31
恭喜恭喜

回复 显示全部楼层 道具 举报

发表于 2015-8-12 13:57:31
可喜可贺,大家一起努力

回复 显示全部楼层 道具 举报

发表于 2015-8-13 09:23:28
Uppsala!
VigiBase!

回复 显示全部楼层 道具 举报

发表于 2015-8-13 12:18:26
VigiBase® is a unique repository of international drug safety data. The data is available in a wide range of services, from advanced statistical analysis to basic case report retrieval
Since 1978 the Uppsala Monitoring Centre (the UMC) has been the focal point of independent global pharmacovigilance. The VigiBase data resource is the largest and most comprehensive in the world, and it is developed and maintained by the UMC on behalf of the World Health Organization (WHO). In VigiBase you find useful information about the safety profile of medicinal products. The services described are used by pharmaceutical companies, academia and national regulatory authorities to obtain safety data with global coverage. VigiBase data is collected from the over 110 countries participating in the WHO Programme for International Drug Monitoring. VigiBase comprises over 10 million Individual Case Safety Reports, ICSRs, and the current growth rate is about 1 million ICSRs each year. ICSRs in VigiBase are primarily spontaneous reports, meaning that they are not generated in controlled clinical trials, but in post-marketing settings, i.e. it is 'real world' data.

Some uses for VigiBase data:

Statistical signal detection
Updating PSURs (Periodic Safety Update Reports)
Comparison with ICSRs in company databases
Comparing domestic and international reporting patterns

回复 显示全部楼层 道具 举报

您需要登录后才可以回帖 登录 | 立即注册

添加常用链接|关于我们|小黑屋|手机版|CDISC中国协调委员会 ( 沪ICP备08020480号

GMT+8, 2018-11-16 10:51 , Processed in 0.391656 second(s), 21 queries .

Powered by Discuz! X3.1

© 2001-2013 Comsenz Inc.

快速回复 返回顶部 返回列表